Urinary prostasin excretion is associated with adiposity in nonhypertensive African-American adolescents.

Urinary prostasin excretion is associated with adiposity in nonhypertensive African-American adolescents.
复制标题

DOI:
10.1038/pr.2013.81
复制
发表时间:
2013-08
期刊:
影响因子:
3.6
通讯作者:
Dong, Yanbin
Dong, Yanbin
中科院分区:
医学3区
文献类型:
--
作者:
Guo, De-huang;Parikh, Samip J.;Chao, Julie;Pollock, Norman K.;Wang, Xiaoling;Snieder, Harold;Navis, Gerjan;Wilson, James G.;Bhagatwala, Jigar;Zhu, Haidong;Dong, Yanbin

文献摘要

参考文献

相似文献

Metabolic abnormalities in obesity can overstimulate the renal epithelial sodium channel (ENaC) and subsequently lead to blood pressure (BP) elevation. Prostasin, a membrane-bound/secretive serine protease, is thought to activate ENaC via the proteolytic cleavage of the channel. Our specific aim was to explore whether there is a relationship between adiposity and urinary prostasin excretion at the population level. In 271 African-American adolescents, urinary prostasin concentrations were determined by enzyme-linked immunosorbent assay and normalized by urinary creatinine. Urinary prostasin excretion increased in the over- weight/obese group (n = 110, 38.2 ± 4.0 ng/mg) vs. the normal-weight group (n = 161, 20.7 ± 1.2 ng/mg, P = 0.03). Urinary prostasin excretion was significantly correlated with BMI percentiles (r = 0.14, P = 0.02), waist circumference (r = 0.13, P = 0.05), total body fat mass (r = 0.20, P < 0.01), and percentage body fat (r = 0.23, P < 0.01). Urinary prostasin excretion was also correlated with plasma aldosterone (r = 0.11, P = 0.05) and systolic BP (SBP; r = 0.15, P = 0.02), but the significances disappeared after adjustment of any of the adiposity variables. Our data for the first time suggest that adiposity plays a role in urinary prostasin excretion, and its associations with aldosterone and BP appear to be modulated by adiposity. Whether urinary prostasin excretion is a biomarker/mechanism underlying obesity-related hypertension deserves further investigations.
DOI: 10.1002/pros.10346
发表时间: 2004-04-01
期刊: PROSTATE
影响因子: 2.8
作者:
Chen, LM;Zhang, XC;Chai, KX
通讯作者: Chai, KX
DOI: 10.1161/01.hyp.0000179582.42830.1d
发表时间: 2005-09-01
期刊: HYPERTENSION
影响因子: 8.3
作者:
Saha, C;Eckert, GJ;Pratt, JH
通讯作者: Pratt, JH
DOI: 10.1161/01.hyp.0000184108.12155.6b
发表时间: 2005-10-01
期刊: HYPERTENSION
影响因子: 8.3
作者:
Olivieri, O;Castagna, A;Righetti, PG
通讯作者: Righetti, PG
DOI: 10.1152/ajprenal.00047.2006
发表时间: 2006-09-01
影响因子: 4.2
作者:
Chen, Li-Mei;Wang, Cindy;Chai, Karl X.
通讯作者: Chai, Karl X.
DOI: 10.1038/sj.ki.5001787
发表时间: 2006-10-01
影响因子: 19.6
作者:
Wakida, N.;Kitamura, K.;Tomita, K.
通讯作者: Tomita, K.